SOLOMON NITTALA

MIAMI, FL NPI 1053995696

General Payments — all program years on this page

$735.18

  • Category: General Payments
  • Program years: PY2024
  • Record count: 20
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $735.18 across 20 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $735.1820

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2024 $735.1820

Records — PY2024 (20)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1087146298 Novartis Pharmaceuticals Corporation $88.41 04/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105129375 ABBVIE INC. $19.10 08/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105129377 ABBVIE INC. $21.60 10/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115972722 Amgen Inc. $111.74 04/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115972728 Amgen Inc. $26.10 08/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115972732 Amgen Inc. $13.66 09/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115972737 Amgen Inc. $25.32 11/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115972742 Amgen Inc. $17.69 12/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1120212682 EMD Serono, Inc. $21.04 07/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136881619 TG Therapeutics, Inc. $31.97 10/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143042313 UCB, Inc. $48.36 01/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143042315 UCB, Inc. $63.68 08/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143042317 UCB, Inc. $2.13 10/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143042319 UCB, Inc. $49.34 10/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143042321 UCB, Inc. $63.71 12/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145951109 Lundbeck LLC $22.78 03/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1146436733 AQUESTIVE THERAPEUTICS, INC. $19.20 11/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150197432 JAZZ PHARMACEUTICALS INC. $19.07 10/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150813776 Neurocrine Biosciences, Inc. $53.70 04/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150870379 Neurocrine Biosciences, Inc. $16.58 03/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.